INTRODUCTION 1.1 OVERVIEW: Trade Related Aspects of Intellectual property Rights was put into effect in the developed countries since Jan 1996. And it will be implemented in Less Developed Countries starting from Jan 2006. Egypt is preparing its pharmaceutical industry for such agreement. A sense of optimism is expressed in the rich North. While a sense of pessimism is expressed in the poor South. Research and Development companies feel quite secure. Reverse Engineering companies (producing imitated
Premium Patent
PHARMACEUTICAL PATENTING IN INDIA:PROBLEM OF PUBLIC ACCESS TO HEALTH TABLE OF CASES 1) Novartis AG v. Union of India‚ (2007) 4 MLJ 1153 2) Bayer Corporation & Others v. Cipla‚ UOI & others‚ 2009(41) PTC 643 (Del). INTRODUCTION A pharmaceutical drug‚ also referred to as medicine‚ is a chemical substance used in the medication or in the preparation of medication for treatment‚ cure‚ prevention or diagnosis of disease. The definition of the term drug includes articles intended for use in
Premium Patent
RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
The Global Pharmaceutical Industry: Swallowing a Bitter Pill The case describes the evolution of the pharmaceutical industry and its strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical needs‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D productivity‚ led
Premium Medicine Pharmacology Industry
Question 1 For each of the following independent situations‚ compute net accounts receivable. a. Accounts Receivable has a balance of $14‚000. The Allowance for Uncollectible Accounts has a credit balance prior to adjustment of $300. An aging schedule prepared on December 31 reveals $1‚100 of uncollectible accounts. b. Accounts Receivable has a balance of $25‚700. The Allowance for Uncollectible Accounts has a debit balance prior to adjustment of $400. An aging schedule
Premium Accounts receivable Generally Accepted Accounting Principles Balance sheet
Domestic drug manufacturers have cast their eyes overseas for growth and four of them have received the certificate of pharmaceutical product (CPP)‚ one of the pre-requisites for obtaining an export licence from the Department of Drug Administration (DDA). According to the DDA‚ Lomus Pharmaceuticals‚ Deurali-Janata Pharmaceuticals‚ Elder Pharmaceuticals and National Health Care Nepal have received the CPP. The CPP is a must for drug manufacturers wanting to export their products. Once the CPP has
Premium Pharmacology Pharmaceutical drug Drug
Background Information: The case is about the dilemma of a product manager of a pharmaceutical company‚ regarding the name of a new product that has failed to capture the market as expected. The case talks about brand extension of an existing brand which has a strong customer base in the field of neurology. It is named after the core brand so that it could enjoy a good brand recall. After completing the market research‚ the teaser campaign is started to attract the target segment i.e. gynecologists
Premium Marketing Neurology Pharmacology
Week Three Discussion Question #1: • Due Date: Day 3 [main forum] • Post your response to the following: You are a division manager at Austen Pharmaceuticals. You directly supervise 50 employees‚ all of who are averages or above average employees. Many individuals on your team have been with the company for several years. Several recent hirers‚ mostly women and minority employees‚ were hired to remedy the lack of financial difficulties within the company; each division manager has
Premium Management Employment Ethics
Problems Faced by Small and Medium Pharmaceutical Companies Small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports are confronted with several issues. These include: lack of expertise‚ training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes;
Premium Pharmacology Pharmaceutical industry Drug
Austen Pharmaceuticals Email Heather Hughey July 17‚ 2013 XMGT-216 Instructor Rebecca Montano To: AustenPharmaceuticalsDivsionManager@Austenpharmaceuticals.net From: HeatherHugheyDivisionManager@Austenpharmaceuticals.net Subject: My plan to decrease Payroll As we both know we have just hired more employees that are minorities and female to correct the lack of diversity in the work place here at Austen Pharmaceuticals. I also understand the budget cuts we have to make to keep the company
Premium Drug Pharmacology Economics